Brief: Ligand Pharmaceuticals Announces Launch Of Pelthos Therapeutics To Accelerate Commercialization Of Zelsuvmi
03/04/2024 14:21
April 3 (Reuters) - Ligand Pharmaceuticals Inc LGND.O :
* LIGAND PHARMACEUTICALS - APPOINTMENT OF SCOTT PLESHA TO
ROLE OF
CEO OF PELTHOS THERAPEUTICS
* LIGAND PHARMACEUTICALS ANNOUNCES LAUNCH OF PELTHOS
THERAPEUTICS
TO ACCELERATE COMMERCIALIZATION OF ZELSUVMI™
* LIGAND PHARMACEUTICALS INC: ZELSUVMI IS EXPECTED TO BE
AVAILABLE
IN UNITED STATES IN LATE 2024
Source text for Eikon: ID:
Further company coverage: LGND.O
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan